# Experimental Ebola Vaccine Trial

> **NCT00072605** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 27 (—)

## Conditions studied

- Hemorrhagic Fever, Ebola
- Healthy

## Interventions

- **DRUG:** VRC-EBODNA012-00-VP

## Key facts

- **NCT ID:** NCT00072605
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-30
- **Primary completion:** —
- **Final completion:** 2007-08-22
- **Target enrollment:** 27 (—)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00072605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00072605, "Experimental Ebola Vaccine Trial". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00072605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*